Literature DB >> 19123323

[Visualized study on acupuncture treatment of children autism using single photon emission computed tomography].

Shao-Wei Jia1, Tao-Tao Sun, Rong Fan.   

Abstract

OBJECTIVE: To provide the molecular iconographic evidence for acupuncture treatment of children autism (CA).
METHODS: Electric acupuncture (EA) was applied on acupoints of bilateral Hegu (LI4), Quchi (LI11), Zusanli (ST36) and Sanyinjiao (SP6) in 34 CA patients' with ABC scale > 57 scores. Using SIEMENS ECAM / ICON double head system, single photon emission computed tomography (SPECT) brain perfusion imaging were performed before and during EA with 99mTc-ECD. Then SPECT images were analyzed visually and quantitatively.
RESULTS: Visual analysis showed that 114 foci of low cerebral perfusion and function were found in 34 CA patients before EA, 28 cases (82.35%) of them with abnormalities in left (or both) front lobes, left Broca area and left Wernicke area. During EA, the affected areas improved to different extent. Quantitative analysis showed that significant difference existed between pre-EA focal Ff and mirror-side Ff, pre-EA Ff and mid-EA Fe, focal BFCR% and mirror-side BFCR % (all P < 0.01). The improving analysis of cerebral perfusion and function showed that the efficacy of EA was 78.95%.
CONCLUSION: Acupuncture was proved preliminarily effective in treating children autism.

Entities:  

Mesh:

Year:  2008        PMID: 19123323

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Involvement of Interleukin-10 in the Anti-Inflammatory Effect of Sanyinjiao (SP6) Acupuncture in a Mouse Model of Peritonitis.

Authors:  Morgana Duarte da Silva; Giselle Guginski; Maria Fernanda de Paula Werner; Cristiane Hatsuko Baggio; Rodrigo Marcon; Adair Roberto Soares Santos
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-05       Impact factor: 2.629

2.  Acupuncture for treatment of autism spectrum disorders.

Authors:  Xue Ming; Xiang Chen; Xiao T Wang; Zhen Zhang; Victor Kang; Barbie Zimmerman-Bier
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-06       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.